Revascularization Modalities in Acute Coronary Syndrome: A Review of the Current State of Evidence.
| Autor: | Surve TA; Internal Medicine, K. J. Somaiya Medical College, Mumbai, IND., Kazim MA; Internal Medicine, Rashid Hospital, Dubai, ARE., Sughra M; Internal Medicine, Gujranwala Teaching Hospital, Gujranwala, PAK., Mirza AMW; Internal Medicine, Jinnah Medical and Dental College, Karachi, PAK., Murugan SK; Internal Medicine, Meenakshi Medical College and Research Institute, Chennai, IND., Shebani KAM; Internal Medicine, University of Zawia, Zawaiya, LBY., Karishma F; Internal Medicine, Ghulam Muhammad Mahar Medical College, Khairpur, PAK., Trada IJ; Internal Medicine, American University of Barbados, Bridgetown, BRB., Mansour M; General Medicine, University of Debrecen, Debrecen, HUN.; General Medicine, Jordan University Hospital, Amman, JOR., Asif K; Medicine and Surgery, Dr. Ruth K. M. Pfau Civil Hospital Karachi, Karachi, PAK., Kaur L; Medicine and Surgery, Government Medical College, Patiala, IND., Kamal A; Medicine, School of Medicine, The University of Jordan, Amman, JOR., Unachukwu N; Medicine, East Tennessee State University, Johnson City, USA., Naveed A; Internal Medicine, Mayo Hospital, Lahore, PAK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Oct 17; Vol. 15 (10), pp. e47207. Date of Electronic Publication: 2023 Oct 17 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.47207 |
| Abstrakt: | Acute coronary syndrome (ACS) stands as a leading global cause of mortality, underscoring the importance of effective prevention, early diagnosis, and timely intervention. While medications offer benefits to many patients, revascularization procedures such as coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), and emerging hybrid approaches remain pivotal for ACS management. This review delves into the 2018 ESC/EACTS guidelines alongside an analysis of existing literature to shed light on the spectrum of revascularization methods. While both CABG and PCI demonstrate promising outcomes, the optimal choice between the two hinges on a comprehensive assessment of individual patient factors, anatomical complexity guided by advanced imaging, comorbidities, and age. The determination of whether to pursue culprit or total revascularization, as well as immediate or staged revascularization, is contingent upon various factors, including age, disease complexity, and clinical outcomes. This evidence-based decision-making process is orchestrated by a multidisciplinary heart team grounded in ongoing clinical evaluation. The primary objective of this review is to provide valuable insights into revascularization strategies and scrutinize the congruence of current guidelines with recent advancements in the field. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Surve et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|